CYTK Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $18,399,907.19

Cytokinetics Insider Trading History Chart

Cytokinetics Share Price & Price History

^$39.48

▲ +0.33 (0.84%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Cytokinetics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/15/2025	John T Henderson	Director	Sell	3,190	$38.66	$123,325.40	66,348
4/10/2025	Robert I Blum	CEO	Sell	5,000	$36.77	$183,850.00	422,629
4/7/2025	Andrew Callos	EVP	Sell	2,886	$35.78	$103,261.08	64,689
4/3/2025	Robert Arthur Harrington	Director	Sell	450	$39.43	$17,743.50	14,658
3/31/2025	Robert I Blum	CEO	Sell	15,000	$40.75	$611,250.00	427,629
3/17/2025	Andrew Callos	EVP	Sell	2,775	$44.38	$123,154.50	34,888
3/17/2025	Robert I Blum	CEO	Sell	12,648	$44.38	$561,318.24	326,533
3/14/2025	Andrew Callos	EVP	Sell	100	$45.00	$4,500.00	37,663
3/6/2025	Andrew Callos	EVP	Sell	3,341	$43.27	$144,565.07	64,434
3/6/2025	Robert I Blum	CEO	Sell	16,970	$43.44	$737,176.80	364,181
2/18/2025	Fady Ibraham Malik	EVP	Sell	2,000	$45.98	$91,960.00	116,071
2/4/2025	Fady Ibraham Malik	EVP	Sell	2,000	$48.06	$96,120.00	116,071
1/21/2025	Fady Ibraham Malik	EVP	Sell	2,000	$45.92	$91,840.00	116,071
1/7/2025	Fady Ibraham Malik	EVP	Sell	2,000	$49.32	$98,640.00	116,071
12/16/2024	Wendall Wierenga	Director	Sell	742	$48.61	$36,068.62	24,559
12/11/2024	John T Henderson	Director	Sell	1,780	$50.42	$89,747.60	38,461
12/10/2024	Fady Ibraham Malik	EVP	Sell	7,300	$50.64	$369,672.00	116,071
12/2/2024	Robert I Blum	CEO	Sell	5,000	$50.76	$253,800.00	397,678
11/26/2024	Fady Ibraham Malik	EVP	Sell	7,300	$50.16	$366,168.00	111,878
11/18/2024	Robert I Blum	CEO	Sell	5,000	$50.55	$252,750.00	397,456
11/12/2024	Fady Ibraham Malik	EVP	Sell	6,342	$58.48	$370,880.16	113,878
11/1/2024	Robert I Blum	CEO	Sell	5,000	$51.63	$258,150.00	397,456
10/30/2024	Fady Ibraham Malik	EVP	Sell	7,300	$51.91	$378,943.00	114,920
10/28/2024	Wendall Wierenga	Director	Sell	4,452	$52.25	$232,617.00	24,559
10/15/2024	Fady Ibraham Malik	EVP	Sell	7,300	$54.19	$395,587.00	116,920
10/9/2024	Robert I Blum	CEO	Sell	5,000	$55.61	$278,050.00	397,456
10/1/2024	Fady Ibraham Malik	EVP	Sell	7,300	$52.10	$380,330.00	118,920
9/30/2024	Robert I Blum	CEO	Sell	5,000	$52.14	$260,700.00	397,456
9/3/2024	Fady Ibraham Malik	EVP	Sell	7,384	$57.01	$420,961.84	122,920
9/3/2024	Robert I Blum	CEO	Sell	5,000	$57.03	$285,150.00	397,456
8/12/2024	B. Lynne Parshall	Director	Sell	5,000	$55.20	$276,000.00	20,600
8/12/2024	Robert I Blum	CEO	Sell	11,500	$55.17	$634,455.00	399,412
8/6/2024	Fady Ibraham Malik	EVP	Sell	7,300	$53.71	$392,083.00	121,704
7/30/2024	Robert I Blum	CEO	Sell	11,500	$59.49	$684,135.00	399,412
7/29/2024	B. Lynne Parshall	Director	Sell	5,000	$59.84	$299,200.00	20,600
7/23/2024	Fady Ibraham Malik	EVP	Sell	7,300	$57.02	$416,246.00	129,004
7/15/2024	B. Lynne Parshall	Director	Sell	5,000	$55.82	$279,100.00	20,600
7/10/2024	Robert I Blum	CEO	Sell	11,500	$54.29	$624,335.00	399,412
7/9/2024	Fady Ibraham Malik	EVP	Sell	7,300	$55.90	$408,070.00	131,004
7/5/2024	Robert Arthur Harrington	Director	Sell	253	$54.61	$13,816.33	15,516
7/1/2024	B. Lynne Parshall	Director	Sell	5,000	$54.22	$271,100.00	20,600
7/1/2024	Robert I Blum	CEO	Sell	11,500	$54.05	$621,575.00	405,145
6/25/2024	Fady Ibraham Malik	EVP	Sell	7,300	$53.72	$392,156.00	133,004
6/17/2024	B. Lynne Parshall	Director	Sell	5,000	$52.55	$262,750.00	20,600
6/17/2024	Robert I Blum	CEO	Sell	22,500	$52.60	$1,183,500.00	416,645
6/11/2024	Fady Ibraham Malik	EVP	Sell	7,788	$53.04	$413,075.52	135,004
6/10/2024	Muna Bhanji	Director	Sell	2,000	$52.07	$104,140.00	17,631
6/4/2024	Robert I Blum	CEO	Sell	22,500	$48.85	$1,099,125.00	439,145
6/3/2024	Robert Arthur Harrington	Director	Sell	1,580	$48.64	$76,851.20	15,541
6/3/2024	Robert Wong	CAO	Sell	13,011	$48.88	$635,977.68	16,653
5/7/2024	Fady Ibraham Malik	EVP	Sell	15,547	$65.11	$1,012,265.17	137,056
4/25/2024	John T Henderson	Director	Sell	10,562	$64.54	$681,671.48	32,070
4/9/2024	Fady Ibraham Malik	EVP	Sell	32,605	$74.31	$2,422,877.55	138,567
3/5/2024	Fady Ibraham Malik	EVP	Sell	32,604	$67.56	$2,202,726.24	138,973
2/14/2024	John T Henderson	Director	Sell	5,000	$76.48	$382,400.00	42,632
2/6/2024	Fady Ibraham Malik	EVP	Sell	32,605	$79.30	$2,585,576.50	142,973
1/31/2024	Robert I Blum	CEO	Sell	12,500	$79.57	$994,625.00	441,797
1/19/2024	Robert I Blum	CEO	Sell	12,500	$81.42	$1,017,750.00	441,797
1/12/2024	John T Henderson	Director	Sell	5,000	$85.14	$425,700.00	42,632
1/4/2024	Fady Ibraham Malik	EVP	Sell	15,678	$86.98	$1,363,672.44	146,973
1/2/2024	Robert I Blum	CEO	Sell	12,500	$85.08	$1,063,500.00	441,797
12/27/2023	Wendall Wierenga	Director	Sell	10,000	$73.60	$736,000.00	18,653
11/15/2023	Robert I Blum	CEO	Sell	12,500	$34.57	$432,125.00	441,417
11/9/2023	Fady Ibraham Malik	EVP	Sell	2,500	$35.40	$88,500.00	150,664
10/30/2023	Robert I Blum	CEO	Sell	12,500	$32.17	$402,125.00	441,417
10/16/2023	Robert I Blum	CEO	Sell	12,500	$33.70	$421,250.00	441,417
10/12/2023	Fady Ibraham Malik	EVP	Sell	2,500	$35.89	$89,725.00	153,164
10/6/2023	Robert I Blum	CEO	Sell	12,500	$30.00	$375,000.00	441,417
9/14/2023	Fady Ibraham Malik	EVP	Sell	2,500	$34.86	$87,150.00	155,664
9/13/2023	Robert I Blum	CEO	Sell	12,500	$34.90	$436,250.00	441,417
8/25/2023	Robert I Blum	CEO	Sell	12,500	$33.99	$424,875.00	441,417
8/21/2023	Wendall Wierenga	Director	Sell	6,020	$32.02	$192,760.40	18,205
8/11/2023	Robert I Blum	CEO	Sell	12,500	$32.37	$404,625.00	441,417
8/1/2023	Robert I Blum	CEO	Sell	12,500	$32.63	$407,875.00	441,417
7/13/2023	Fady Ibraham Malik	EVP	Sell	2,500	$35.37	$88,425.00	160,664
7/13/2023	Robert I Blum	CEO	Sell	12,500	$35.28	$441,000.00	441,417
7/7/2023	Muna Bhanji	Director	Sell	2,000	$34.12	$68,240.00	14,031
7/3/2023	Robert I Blum	CEO	Sell	12,500	$32.60	$407,500.00	441,417
6/12/2023	Robert I Blum	CEO	Sell	12,500	$37.06	$463,250.00	441,417
6/8/2023	Fady Ibraham Malik	EVP	Sell	2,500	$38.07	$95,175.00	163,164
5/31/2023	Robert I Blum	CEO	Sell	12,500	$37.67	$470,875.00	441,058
5/16/2023	Robert I Blum	CEO	Sell	12,500	$37.41	$467,625.00	441,058
5/15/2023	John T Henderson	Director	Sell	4,166	$37.77	$157,349.82	25,420
5/11/2023	Fady Ibraham Malik	EVP	Sell	1,787	$39.50	$70,586.50	165,396
5/3/2023	Fady Ibraham Malik	EVP	Sell	7,000	$40.00	$280,000.00	167,183
4/28/2023	Robert I Blum	CEO	Sell	12,500	$37.68	$471,000.00	441,058
4/14/2023	Robert I Blum	CEO	Sell	12,500	$35.61	$445,125.00	441,058
4/13/2023	Fady Ibraham Malik	EVP	Sell	4,000	$34.21	$136,840.00	167,183
3/28/2023	Robert I Blum	CEO	Sell	12,500	$35.05	$438,125.00	441,058
3/15/2023	Robert I Blum	CEO	Sell	12,500	$37.26	$465,750.00	441,058
3/9/2023	Fady Ibraham Malik	EVP	Sell	4,000	$39.10	$156,400.00	171,183
3/6/2023	Robert I Blum	CEO	Sell	12,500	$39.94	$499,250.00	370,458
2/21/2023	Robert Wong	CAO	Sell	2,234	$45.21	$100,999.14	24,789
2/9/2023	Fady Ibraham Malik	EVP	Sell	4,000	$43.73	$174,920.00	152,589
2/3/2023	Robert Wong	CAO	Sell	3,004	$45.00	$135,180.00	27,533
1/17/2023	Robert I Blum	CEO	Sell	10,000	$42.43	$424,300.00	406,412
1/12/2023	Fady Ibraham Malik	EVP	Sell	4,000	$40.47	$161,880.00	156,589
1/4/2023	Robert I Blum	CEO	Sell	10,000	$44.24	$442,400.00	406,412
12/5/2022	Robert I Blum	CEO	Sell	10,000	$39.30	$393,000.00	406,412
11/14/2022	Robert Wong	CAO	Sell	2,100	$40.68	$85,428.00	30,537
11/10/2022	Fady Ibraham Malik	EVP	Sell	4,000	$38.04	$152,160.00	164,346
11/2/2022	Robert I Blum	CEO	Sell	10,000	$42.17	$421,700.00	406,089
10/19/2022	Robert I Blum	CEO	Sell	10,000	$47.86	$478,600.00	406,089
10/13/2022	Fady Ibraham Malik	EVP	Sell	21,513	$47.28	$1,017,134.64	168,346
10/3/2022	Robert I Blum	CEO	Sell	10,000	$50.40	$504,000.00	406,089
9/19/2022	Robert I Blum	CEO	Sell	10,000	$51.42	$514,200.00	406,089
9/12/2022	John T Henderson	Director	Sell	21,759	$54.94	$1,195,439.46	24,049
9/8/2022	Fady Ibraham Malik	EVP	Sell	21,500	$51.88	$1,115,420.00	168,346
9/7/2022	Robert I Blum	CEO	Sell	10,000	$49.11	$491,100.00	406,089
8/17/2022	Robert I Blum	CEO	Sell	10,000	$50.11	$501,100.00	409,124
8/1/2022	Robert I Blum	CEO	Sell	10,000	$41.26	$412,600.00	409,124
7/18/2022	Robert I Blum	CEO	Sell	10,000	$40.49	$404,900.00	409,472
7/14/2022	Fady Ibraham Malik	EVP	Sell	21,500	$43.43	$933,745.00	168,346
7/6/2022	Robert I Blum	CEO	Sell	10,000	$44.38	$443,800.00	409,472
6/6/2022	Robert I Blum	CEO	Sell	10,000	$41.23	$412,300.00	409,472
5/16/2022	Robert I Blum	CEO	Sell	10,000	$43.11	$431,100.00	409,124
5/12/2022	Fady Ibraham Malik	EVP	Sell	13,987	$37.54	$525,071.98	168,084
5/4/2022	Robert I Blum	CEO	Sell	10,000	$39.43	$394,300.00	409,124
4/20/2022	Robert I Blum	CEO	Sell	10,000	$37.89	$378,900.00	409,124

See Full Table

SEC Filings (Institutional Ownership Changes) for Cytokinetics (NASDAQ:CYTK)

Institutional Buying and Selling by Quarter

Cytokinetics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/15/2025	Fifth Third Bancorp	981	$39K	0.0%	+42.2%	0.001%
4/15/2025	GAMMA Investing LLC	1,120	$45K	0.0%	+281.0%	0.001%
4/14/2025	Yousif Capital Management LLC	41,660	$1.67M	0.0%	-2.6%	0.035%
4/14/2025	Harbor Capital Advisors Inc.	53,113	$2.14M	0.1%	+17.7%	0.045%
4/14/2025	UMB Bank n.a.	1,156	$46K	0.0%	+91.4%	0.001%
4/11/2025	E. Ohman J or Asset Management AB	329,231	$13.23M	0.4%	N/A	0.278%
4/9/2025	RFG Advisory LLC	32,005	$1.29M	0.0%	N/A	0.027%
4/9/2025	Mirador Capital Partners LP	99,125	$3.98M	0.7%	+51.0%	0.084%
4/8/2025	Rhumbline Advisers	373,855	$15.03M	0.0%	-2.6%	0.316%
4/8/2025	Parallel Advisors LLC	1,099	$44K	0.0%	+500.5%	0.001%
4/7/2025	GAMMA Investing LLC	45,013	$1.81M	0.0%	+15,210.5%	0.038%
3/17/2025	Wealth Enhancement Advisory Services LLC	6,656	$0.31M	0.0%	-29.4%	0.006%
2/27/2025	Jefferies Financial Group Inc.	12,600	$0.59M	0.0%	-98.9%	0.011%
2/19/2025	GF Fund Management CO. LTD.	2,478	$0.12M	0.0%	N/A	0.002%
2/18/2025	Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.	329,136	$15.48M	1.9%	N/A	0.279%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	315,250	$14.83M	0.0%	-52.7%	0.267%
2/17/2025	Woodline Partners LP	126,201	$5.94M	0.0%	-2.2%	0.107%
2/17/2025	Zimmer Partners LP	38,000	$1.79M	0.0%	-50.8%	0.032%
2/17/2025	Vestal Point Capital LP	2,350,000	$110.54M	6.6%	+56.7%	1.991%
2/17/2025	Two Sigma Advisers LP	226,400	$10.65M	0.0%	+5.4%	0.192%
2/17/2025	Tidal Investments LLC	9,965	$0.47M	0.0%	-3.6%	0.008%
2/17/2025	Teza Capital Management LLC	9,488	$0.45M	0.1%	N/A	0.008%
2/17/2025	Tema Etfs LLC	47,383	$2.23M	0.9%	N/A	0.040%
2/17/2025	Thornburg Investment Management Inc.	281,862	$13.26M	0.2%	-0.6%	0.239%
2/17/2025	Stempoint Capital LP	83,576	$3.93M	1.0%	+477.8%	0.071%
2/17/2025	Sarissa Capital Management LP	833,799	$39.22M	12.1%	-24.9%	0.707%
2/17/2025	Rafferty Asset Management LLC	167,935	$7.90M	0.0%	-22.5%	0.142%
2/17/2025	Redmile Group LLC	92,598	$4.36M	0.3%	-4.7%	0.078%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	1,849	$87K	0.0%	N/A	0.002%
2/17/2025	ProShare Advisors LLC	43,299	$2.04M	0.0%	+28.6%	0.037%
2/17/2025	Nuveen Asset Management LLC	373,229	$17.56M	0.0%	-2.6%	0.316%
2/17/2025	Orbimed Advisors LLC	1,584,005	$74.51M	1.6%	+106.5%	1.342%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	71,658	$3.37M	0.0%	+0.9%	0.061%
2/17/2025	Integral Health Asset Management LLC	1,000,000	$47.04M	4.0%	+33.3%	0.847%
2/17/2025	Janus Henderson Group PLC	1,024,417	$48.18M	0.0%	-10.4%	0.868%
2/17/2025	Jefferies Financial Group Inc.	12,600	$0.59M	0.0%	-98.9%	0.011%
2/17/2025	Hudson Bay Capital Management LP	141,269	$6.65M	0.0%	+109.3%	0.120%
2/17/2025	Ensign Peak Advisors Inc	296,835	$13.96M	0.0%	-35.7%	0.252%
2/17/2025	Clearline Capital LP	166,477	$7.83M	1.0%	-19.8%	0.141%
2/17/2025	Deep Track Capital LP	2,500,000	$117.60M	4.4%	+296.9%	2.118%
2/17/2025	Corton Capital Inc.	4,669	$0.22M	0.1%	-26.2%	0.004%
2/17/2025	Cetera Investment Advisers	4,551	$0.21M	0.0%	-82.5%	0.004%
2/17/2025	Brevan Howard Capital Management LP	8,976	$0.42M	0.0%	N/A	0.008%
2/17/2025	Brown Advisory Inc.	1,076,431	$50.64M	0.1%	-7.7%	0.912%
2/17/2025	BNP Paribas Financial Markets	24,647	$1.16M	0.0%	-38.8%	0.021%
2/17/2025	Ameriprise Financial Inc.	752,401	$35.39M	0.0%	+38.8%	0.638%
2/17/2025	Algert Global LLC	58,680	$2.76M	0.1%	+20.6%	0.050%
2/17/2025	Alyeska Investment Group L.P.	150,000	$7.06M	0.0%	+500.0%	0.127%
2/17/2025	Allostery Investments LP	65,000	$3.06M	3.2%	N/A	0.055%
2/14/2025	Fifth Lane Capital LP	6,000	$0.28M	0.8%	+50.0%	0.005%
2/14/2025	Comerica Bank	235,464	$11.08M	0.0%	-0.7%	0.200%
2/14/2025	Northern Trust Corp	1,471,489	$69.22M	0.0%	+10.7%	1.247%
2/14/2025	The Manufacturers Life Insurance Company	188,538	$8.87M	0.0%	-12.2%	0.160%
2/14/2025	Quarry LP	800	$38K	0.0%	-73.3%	0.001%
2/14/2025	Melqart Asset Management UK Ltd	1,136,434	$53.46M	6.5%	-6.3%	0.963%
2/14/2025	Decheng Capital LLC	100,000	$4.70M	1.0%	+6.3%	0.085%
2/14/2025	Aquatic Capital Management LLC	175,553	$8.26M	0.2%	+131.3%	0.149%
2/14/2025	Boothbay Fund Management LLC	83,370	$3.92M	0.1%	-21.4%	0.071%
2/14/2025	Susquehanna Fundamental Investments LLC	131,799	$6.20M	0.1%	N/A	0.112%
2/14/2025	Virtus ETF Advisers LLC	1,415	$67K	0.0%	-19.0%	0.001%
2/14/2025	Gilder Gagnon Howe & Co. LLC	11,892	$0.56M	0.0%	-12.3%	0.010%
2/14/2025	Voya Investment Management LLC	80,463	$3.79M	0.0%	+14.6%	0.068%
2/14/2025	Hood River Capital Management LLC	989,248	$46.53M	0.7%	-0.2%	0.838%
2/14/2025	T. Rowe Price Investment Management Inc.	10,752,123	$505.78M	0.3%	+11.0%	9.111%
2/14/2025	Pinebridge Investments L.P.	36,404	$1.71M	0.0%	+42.7%	0.031%
2/14/2025	Price T Rowe Associates Inc. MD	2,625,081	$123.49M	0.0%	-17.1%	2.224%
2/14/2025	J. Safra Sarasin Holding AG	13,027	$0.61M	0.0%	N/A	0.011%
2/14/2025	State of Tennessee Department of Treasury	44,866	$2.11M	0.0%	-2.7%	0.038%
2/14/2025	Tower Research Capital LLC TRC	16,920	$0.80M	0.0%	+86.8%	0.014%
2/14/2025	Teachers Retirement System of The State of Kentucky	55,075	$2.59M	0.0%	-3.2%	0.047%
2/14/2025	MetLife Investment Management LLC	133,702	$6.29M	0.0%	+8.4%	0.113%
2/14/2025	Dimensional Fund Advisors LP	94,124	$4.43M	0.0%	-21.5%	0.080%
2/14/2025	Capital International Investors	1,096,164	$51.56M	0.0%	N/A	0.929%
2/13/2025	CANADA LIFE ASSURANCE Co	76,460	$3.59M	0.0%	-14.2%	0.065%
2/13/2025	Marshall Wace LLP	2,153,313	$101.29M	0.1%	+14.9%	1.825%
2/13/2025	Gabelli Funds LLC	5,000	$0.24M	0.0%	-7.4%	0.004%
2/13/2025	Ontario Teachers Pension Plan Board	10,758	$0.51M	0.0%	-4.0%	0.009%
2/13/2025	Guggenheim Capital LLC	35,988	$1.69M	0.0%	-12.0%	0.030%
2/13/2025	Sterling Capital Management LLC	3,332	$0.16M	0.0%	+805.4%	0.003%
2/13/2025	Quinn Opportunity Partners LLC	115,939	$5.45M	0.4%	+8.7%	0.098%
2/13/2025	Kennedy Capital Management LLC	6,423	$0.30M	0.0%	+22.3%	0.005%
2/13/2025	Capital Fund Management S.A.	40,446	$1.90M	0.0%	+13.9%	0.034%
2/13/2025	Bessemer Group Inc.	551	$26K	0.0%	-71.5%	0.000%
2/13/2025	Raymond James Financial Inc.	5,400	$0.25M	0.0%	N/A	0.005%
2/13/2025	Advisory Services Network LLC	5,739	$0.27M	0.0%	N/A	0.005%
2/13/2025	Renaissance Technologies LLC	192,167	$9.04M	0.0%	-21.4%	0.163%
2/13/2025	Legal & General Group Plc	178,632	$8.40M	0.0%	-1.2%	0.151%
2/13/2025	Bank of Montreal Can	15,136	$0.71M	0.0%	+9.3%	0.013%
2/13/2025	Cerity Partners LLC	4,066	$0.21M	0.0%	-21.0%	0.003%
2/13/2025	Federated Hermes Inc.	37,101	$1.75M	0.0%	+10.6%	0.031%
2/13/2025	Finepoint Capital LP	318,448	$14.98M	0.9%	+24.2%	0.270%
2/13/2025	Springhill Fund Asset Management HK Co Ltd	130,735	$6.15M	10.0%	N/A	0.111%
2/13/2025	Envestnet Asset Management Inc.	26,455	$1.24M	0.0%	-20.0%	0.022%
2/13/2025	Rhenman & Partners Asset Management AB	149,250	$7.02M	0.7%	-17.3%	0.126%
2/12/2025	ExodusPoint Capital Management LP	9,324	$0.44M	0.0%	-92.1%	0.008%
2/12/2025	Cynosure Group LLC	5,800	$0.27M	0.0%	-15.6%	0.005%
2/12/2025	Massachusetts Financial Services Co. MA	319,281	$15.02M	0.0%	-7.3%	0.271%
2/12/2025	Groupama Asset Managment	350,000	$16.46M	0.1%	N/A	0.297%
2/12/2025	Headlands Technologies LLC	2,067	$97K	0.0%	N/A	0.002%
2/12/2025	Geode Capital Management LLC	2,841,338	$133.69M	0.0%	-0.3%	2.408%

Data available starting January 2016

See Full Table

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; CK-586, a small molecule cardiac myosin inhibitor, that is in Phase I clinical trial; and aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy. Cytokinetics, Incorporated has a strategic alliance with Ji Xing Pharmaceuticals Limited. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

Today's Range

Now: $39.48

$38.41

$39.53

50 Day Range

MA: $42.63

$34.57

$51.12

52 Week Range

Now: $39.48

$32.74

$68.76

Volume

1,075,537 shs

Average Volume

1,596,021 shs

Market Capitalization

$4.71 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of Cytokinetics?: Cytokinetics' top insider shareholders include:
Robert I Blum (CEO)
Fady Ibraham Malik (EVP)
John T Henderson (Director)
Andrew Callos (EVP)
Wendall Wierenga (Director)
B Lynne Parshall (Director)
Muna Bhanji (Director)
Robert Wong (CAO)
Robert Arthur Harrington (Director)
Learn More about top insider investors at Cytokinetics.
Who are the major institutional investors of Cytokinetics?: Cytokinetics' top institutional shareholders include:
Rhumbline Advisers — 0.32%
E. Ohman J or Asset Management AB — 0.28%
Mirador Capital Partners LP — 0.08%
Harbor Capital Advisors Inc. — 0.04%
GAMMA Investing LLC — 0.04%
Yousif Capital Management LLC — 0.03%
Learn More about top institutional investors of Cytokinetics stock.
Which major investors are selling Cytokinetics stock?: During the previous quarter, CYTK stock was sold by these institutional investors:
Rhumbline Advisers
Yousif Capital Management LLC
Within the previous year, company insiders that have sold Cytokinetics company stock include:
Robert I Blum (CEO)
Fady Ibraham Malik (EVP)
John T Henderson (Director)
Andrew Callos (EVP)
Wendall Wierenga (Director)
B Lynne Parshall (Director)
Muna Bhanji (Director)
Robert Wong (CAO)
Robert Arthur Harrington (Director)
Learn More investors selling Cytokinetics stock.
Which major investors are buying Cytokinetics stock?: In the previous quarter, CYTK stock was purchased by institutional investors including:
E. Ohman J or Asset Management AB
GAMMA Investing LLC
Mirador Capital Partners LP
RFG Advisory LLC
Harbor Capital Advisors Inc.
Parallel Advisors LLC
GAMMA Investing LLC
UMB Bank n.a.